[1] Ashmila H, Khatoon N, Keaveny A, et al. Intrinsic causes of nonfibrotic portal hypertension-A clinicopathologic review of 56 patients[J]. Int J Surg Pathol, 2025, 33(3):571-576.
[2] Lampichler K, Semmler G, Wöran K, et al. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder[J]. Eur Radiol, 2023, 33(2): 1422-1432.
[3] Kang J H, Kim D H, Kim S Y, et al. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI[J]. Abdom Radiol (NY), 2021, 46(5): 1891-1903.
[4] De Gottardi A, Rautou P E, Schouten J, et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity[J]. Lancet Gastroenterol Hepatol, 2019, 4(5): 399-411.
[5] De Gottardi A, Sempoux C, Berzigotti A. Porto-sinusoidal vascular disorder[J]. J Hepatol, 2022, 77(4): 1124-1135.
[6] Fan C Q, Crawford J M. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)[J]. J Clin Exp Hepatol, 2014, 4(4): 332-346.
[7] Nakanuma Y, Nonomura A, Hayashi M, et al. Pathology of the liver in “idiopathic portal hypertension” associated with autoimmune disease. The ministry of health and welfare disorders of portal circulation research committee[J]. Acta Pathol Jpn, 1989, 39(9): 586-592.
[8] Gracia-Sancho J, Marrone G, Fernández-Iglesias A. Hepatic microcirculation and mechanisms of portal hypertension[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(4): 221-234.
[9] Kmeid M, Liu X, Ballentine S, et al. Idiopathic non-cirrhotic portal hypertension and porto-sinusoidal vascular disease: review of current data[J]. Gastroenterology Res, 2021, 14(2): 49-65.
[10] Huang X, Li F, Wang L, et al. Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer[J]. Endoscopy, 2020, 52(9): 727-735.
[11] 齐婧姝, 王宇, 刘成海. 活血化瘀法在肝硬化中医药治疗中的实践应用与发展[J]. 上海中医药杂志, 2023, 57(8): 27-32.
[12] 魏武英, 李佺. 血证论[M]. 北京: 人民卫生出版社, 2020. |
